Please login to the form below
2019-nCov
This page shows the latest 2019-nCov news and features for those working in and with pharma, biotech and healthcare.
UPDATED: J&J expands US partnership for coronavirus treatments
Worst-case scenario modelling for COVID-19 – also known as 2019-nCov – suggests it could infect 60% of the world’s population with a 1% fatality rate, and that the numbers
Latest news
-
Four more coronavirus cases confirmed in the UK
The number of confirmed cases of the coronavirus – also known as 2019-nCoV – in the UK has now doubled from the previously announced four, with the Department of Health and Social ... to detect the coronavirus in “individuals who meet CDC criteria
-
GSK and Gilead join global efforts to tackle novel coronavirus
The coronavirus – also known as 2019-nCoV or Wuhan coronavirus – has afflicted 17, 000 people in China, and over 150 in other countries. ... Chinese Center for Disease Control and Prevention, which included drug-screening for antiviral properties
-
UK confirms first cases of coronavirus as global concerns mount
It is not clear yet whether they had travelled to China recently or have contracted coronavirus strain 2019-nCov from someone else who had done so. ... 2019-nCov is now a public health emergency of international concern (PHEIC), it said, while also
-
J&J begins search for a coronavirus vaccine as confirmed cases rise
The coronavirus – also known as 2019-nCoV – is believed to have originated from illegally traded wildlife at a seafood market in Wuhan City, Hubei province of China. ... In response to the rising fears surrounding the coronavirus, J&J will
Four more coronavirus cases confirmed in the UK
GSK and Gilead join global efforts to tackle novel coronavirus
J&J begins search for a coronavirus vaccine as confirmed cases rise
More from news
Approximately 3 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
WHITE PAPER: From bench to bedside in one year - how the race for a COVID-19 vaccine will change the future of drug development
CDC. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different vaccines/viralvector.html. Published April 13, 2021. Accessed June 10, 2021. ... Hutchings M, et al. Antibiotics: past, present and future. Curr Opin Microbiol.2019; 51:72-80.
WHITE PAPER: From bench to bedside in one year - how the race for a COVID-19 vaccine will change the future of drug development
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
-
Events Executive
-
Depending on Experience
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
-
Digital strategist
-
Competitive
- Client Services Director +, Remote or London – Leadership Opport...
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
-
Digital account director
-
Competitive
- FREELANCE (Outside IR35) Opportunities for this week below!!!
-
Superb Day Rate
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
-
Digital project manager
-
Competitive
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy
- Israel study suggests Pfizer/BioNTech vaccine is less effective against Delta variant
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- bluebird bio to restart marketing of Zynteglo in EU after previous suspension
- Live Webinar: Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
- Another Landmark Lucid Workiversary
- Amgen pays $900m upfront to acquire Teneobio’s antibody assets, R&D technologies
- Biogen and Eisai present new data for controversial Alzheimer's drug Aduhelm at AAIC
- AZ publishes new real-world safety data for COVID-19 vaccine Vaxzevria
- EU approves bluebird bio’s CALD gene therapy Skysona
- Onyx Health Launch Creative Studio After Record Year
- BioNTech plans acquisition of Kite’s TCR cell therapy R&D platform
- FDA advisory committee votes against approval of AZ, FibroGen's roxadustat
- This month in 1939: How dead cattle led to the discovery of warfarin
- Recruiting patients for real-world studies – the power of a digital campaign
PMHub
Purple Agency
An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....
Latest intelligence
- Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
- The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
- Employee wellbeing in creative agencies: three tips to get you started
- Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
- Managing unhelpful pressure in your creative agency: the human approach
- Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...
